Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Insulet Corporation, 3 years.
Insulet Corporation
Director
Royalty Pharma plc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Royalty Pharma plc June 4, 2026100.0%
-
Insulet Corporation May 22, 202594.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Royalty Pharma plc | Grant or award | +4,545 | — | — |
| Jun 3, 2026 | Insulet Corporation | Open-market purchase | +3,450 | $144.20 | $497,490 |
| May 20, 2026 | Insulet Corporation | Grant or award | +1,660 | — | — |
| Jul 31, 2025 | Royalty Pharma plc | Grant or award | +2,752 | — | — |
| Jul 31, 2025 | Royalty Pharma plc | Grant or award | +5,806 | — | — |
| May 22, 2025 | Insulet Corporation | Grant or award | +778 | — | — |
| May 22, 2024 | Insulet Corporation | Grant or award | +1,380 | — | — |
| May 23, 2023 | Insulet Corporation | Grant or award | +843 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.